Balco Medical Centre is leading hematology research with a focus on leukemia, lymphoma, and multiple myeloma. Dr. Dibyendu De and his team conduct clinical trials and translational research to bring innovative therapies to patients.
Research highlights include CRISPR-mediated correction of genetic blood disorders, novel drug trials for myeloma, and AI-based prediction models for infection risk. These studies are improving survival rates and optimizing patient care.